MXC could buy out Medlab's succesful late-stage cancer pain cannabis drug for 24 million dollars$ and still have 20 million dollars@ left over, going on market caps. lmao.
- Forums
- ASX - By Stock
- Ann: Medlab Progresses Nasdaq Dual Listing
MXC could buy out Medlab's succesful late-stage cancer pain...
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable